Literature DB >> 8243592

Epidemiology of cardiovascular disease risk factors in Catalonia (Spain).

P Plans1, H Pardell, L Salleras.   

Abstract

Cardiovascular disease is one of the most important public health problems in developed countries. We have studied the epidemiology of the following cardiovascular disease risk factors in a random sample (n = 704) of the adult population of Catalonia (Spain): hypercholesterolemia (> or = 6.1) mmol/l or 240 mg/dl), hypertension (SBP > or = 160 and/or DBP > or = 95 mmHg), low HDL-cholesterol concentrations (< 0.9 mmol/l or 35 mg/dl), hypertriglyceridemia (> 2.8 mmol/l or 250 mg/dl), obesity (BMI > 30), smoking and history of diabetes and coronary heart disease. Two percent of participants had hypertriglyceridemia, 3% had a history of coronary heart disease, 4% a history of diabetes, 6% low HDL-cholesterol concentrations, 12% were obese, 20% had hypertension, 24% had hypercholesterolemia and 36% were smokers. 58% of hypertensive individuals had been previously detected, 46% were currently on treatment, and 21% had their blood pressure controlled (SBP < 160 and DBP < 95 mmHg). Correlation and multiple regression analyses were used to investigate the association between cardiovascular risk factors. Multiple linear regression analysis showed independent correlations between risk factors. Prevalence of hypercholesterolemia, obesity and diabetes was higher and prevalence of smoking was lower in hypertensives than normotensives. The odds ratio was 3.68 (95% CI = 2.07-6.54) for hypercholesterolemia, 3.26 (95% CI = 1.52-7.02) for obesity, 3.81 (95% CI = 1.09-7.02) for diabetes and 0.40 (95% CI = 0.22-0.70) for smoking. The adjusted odds ratio was statistically significant for hypercholesterolemia (OR = 2.74, 95% CI = 1.01-3.75). The prevalence of cardiovascular risk factors was similar to that observed in other Mediterranean communities.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8243592     DOI: 10.1007/bf00157394

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  31 in total

Review 1.  Regulation of lipoprotein metabolism by adrenergic mechanisms.

Authors:  V J Dzau; F M Sacks
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

2.  [Hypertension, obesity, alcohol, tobacco and caffeine consumption before vascular diseases, in the statutory community of Navarra].

Authors:  A Martínez; R Izquierdo; I Balanzategui
Journal:  Rev Clin Esp       Date:  1987-01       Impact factor: 1.556

3.  [Prevalence of arterial hypertension in L'Hospitalet de Llobregat (Barcelona)].

Authors:  H Pardell Alentá; J M Gasulla Roso; P Armario García; R Hernández del Rey
Journal:  Med Clin (Barc)       Date:  1983-10-29       Impact factor: 1.725

4.  Studies on serum lipoproteins and lipid metabolism. Analysis of a random sample of 40 year old men.

Authors:  A G Olsson; G Walldius; S Rössner; E Callmer; L Kaijser
Journal:  Acta Med Scand Suppl       Date:  1980

5.  The cardiovascular disease study in Norwegian counties. Results from first screening.

Authors:  K Bjartveit; O P Foss; T Gjervig
Journal:  Acta Med Scand Suppl       Date:  1983

6.  Adrenergic mechanisms in the control of plasma lipids in man.

Authors:  J L Day; J Metcalfe; N Simpson; L Lowenthal
Journal:  Am J Med       Date:  1984-02-27       Impact factor: 4.965

7.  [Arterial hypertension in the island of Tenerife. I. Incidence (author's transl)].

Authors:  J Dorta Delgado; H Pérez Hernández; J Batista Martín; J M Dorta Delgado; C Glez Caloca; M Linares Feria; L Abrahán Pérez; A López Linares
Journal:  Med Clin (Barc)       Date:  1979-12-15       Impact factor: 1.725

8.  Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

Authors:  J Stamler; D Wentworth; J D Neaton
Journal:  JAMA       Date:  1986-11-28       Impact factor: 56.272

9.  Geographical variation in the major risk factors of coronary heart disease in men and women aged 35-64 years. The WHO MONICA Project.

Authors: 
Journal:  World Health Stat Q       Date:  1988

Review 10.  Hypertension as a disease of carbohydrate and lipoprotein metabolism.

Authors:  G M Reaven; B B Hoffman
Journal:  Am J Med       Date:  1989-12-08       Impact factor: 4.965

View more
  8 in total

1.  Prevalence and control of arterial hypertension in the south-east of Spain: a radical but still insufficient improvement.

Authors:  M J Tormo; C Navarro; M D Chirlaque; D Pérez-Flores
Journal:  Eur J Epidemiol       Date:  1997-04       Impact factor: 8.082

2.  Low apolipoprotein E epsilon4 allele frequency in the population of Catalonia (Spain) determined by PCR-RFLP and Laser fluorescent sequencer.

Authors:  M Gené; P Moreno; M Ezquerra; A Prat; E Huguet; R Adroer; R Oliva
Journal:  Eur J Epidemiol       Date:  1997-10       Impact factor: 8.082

3.  Cost-effectiveness analysis of treatments to reduce cholesterol levels, blood pressure and smoking for the prevention of coronary heart disease: evaluative study carried out in Spain.

Authors:  P Plans-Rubió
Journal:  Pharmacoeconomics       Date:  1998-05       Impact factor: 4.981

Review 4.  Management of the hypertensive patient who smokes.

Authors:  H Pardell; R Tresserras; E Saltó; P Armario; R Hernández
Journal:  Drugs       Date:  1998-08       Impact factor: 9.546

5.  Life-style factors associated with changes in serum lipids in a follow-up study of cardiovascular risk factors.

Authors:  M A Martínez-González; J Fernández-García; F Sánchez-Izquierdo; P Lardelli-Claret; J Jiménez Moléon; R Gálvez-Vargas
Journal:  Eur J Epidemiol       Date:  1998-09       Impact factor: 8.082

6.  Changes in coronary risk profiles in employees after three years of multifactorial intervention.

Authors:  M A Martínez-González; A Bueno-Cavanillas; F Sánchez-Izquierdo; I Aguinaga Ontoso; J J Jiménez-Moléon; M Delgado-Rodríguez
Journal:  Eur J Epidemiol       Date:  1998-10       Impact factor: 8.082

7.  Allocation of resources between smoking cessation methods and lovastatin treatment of hypercholesterolaemia: based on cost effectiveness and the social welfare function.

Authors:  Pedro Plans-Rubió
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

8.  Plasma total cholesterol level and some related factors in northern Iranian people.

Authors:  Gholamreza Veghari; Mehdi Sedaghat; Hamidraza Joshghani; Farhad Niknezad; Abdolhamid Angizeh; Ebrahim Tazik; Pooneh Moharloei; Samieh Banihashem
Journal:  J Nat Sci Biol Med       Date:  2013-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.